Shawn O'Brien

Alto Pharmaceuticals Ltd. Develops and commercialize products for maintaining a healthy lifestyle and improving quality of life. The firm’s area of interest includes dermatology and skin care, as well as post surgical support. The company was founded by Joan Chypyha in 2008 and is headquartered in Oakridges, Canada.

SFA Therapeutics, Inc. is a clinical-stage biotech company based on breakthrough research of the human microbiome licensed from Temple University. SFA Therapeutics is located in Jenkintown, PA. Ira Spector has been the CEO of the company since 2017. The company is developing a platform of safer therapeutics focused on the treatment of inflammatory diseases, targeting NF-kB and RAS. SFA has identified six small molecule drug candidates from this platform, including its lead asset, SFA-002, which has shown promising phase 1a results and is currently being investigated in a phase 1b study for psoriasis. The company's research program is focused on the intersection of chronic inflammation and cancer.

Crozer-Keystone Health System provides full spectrum of wellness, prevention, acute care, rehabilitation and restorative care to the community. It services includes a Level 2 trauma center; a regional burn center; three regional cancer centers affiliated with Fox Chase Cancer Center; a fertility center; sleep-disorders centers; wound care centers with hyperbaric medicine; comprehensive maternity services, including intensive care nurseries and maternal fetal medicine; a kidney transplant center; advanced heart care services, including open heart surgery; orthopedic services, sports medicine and physical therapy and rehabilitation services; senior health services; a bariatric surgery program; medical imaging services; and a comprehensive physician network of primary-care and specialty practices. The company was founded in 1990 and is headquartered in Springfield, PA.

Melanovus Oncology, Inc. provides laboratory testing services. It focuses on discovering, developing and commercializing new therapeutics, diagnostics and topically delivered compounds for late stage melanoma and other skin cancers. The company was founded in 2012 and is headquartered in Jensen Beach, FL.

Altherx, Inc. operates as a clinical development company. The company was founded on May 11, 2010 and is headquartered in Glenmoore, PA.

Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD.